动脉粥样硬化性心血管疾病预防 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality
Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes
Associations between Blood Lead Levels and Coronary Artery Stenosis Measured Using Coronary Computed Tomography Angiography
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA)
Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology
When, where, and how to target vascular inflammation in the post-CANTOS era?
MINOCA: a heterogenous group of conditions associated with myocardial damage
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?

Expert Opinion

03 January 2021

JOURNAL：Eur Heart J.

The Year in Cardiovascular Medicine 2020: Coronary Prevention: Looking back on the Year in Cardiovascular Medicine for 2020 in the field of coronary prevention is Professor Ramon Estruch, Dr Luis Ruilope, and Professor Francesco Cosentino. Mark Nicholls meets them

M Nicholls.

4242

Keywords: coronay prevention; heart disease

Full Text PDF